SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

SNDX is trending due to positive sentiment following a competitor's drug rejection by the EMA, which strengthens the value of SNDX's pipeline. The community is discussing the potential strategic advantage this gives SNDX in the cGvHD market, while also awaiting a catalyst with an upcoming PDUFA date. Investors are also analyzing the high short interest and potential for a squeeze.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as traders discuss its potential for a short squeeze, fueled by high borrowing costs for shorts and a relatively small float. Community members are analyzing short interest data and speculating on potential catalysts, including further insider buying. Some traders express concerns about potential manipulation and are closely watching order flow and short selling activity.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending amid discussions around its Q3 earnings, with community members weighing in on whether to buy puts or take profits, particularly with Ford cutting its 2025 adjusted EBIT view. Despite positive earnings, the fire at the Novelis plant and its potential impact on future production are key concerns. Broader market sentiment and the stock's technical levels are also being closely watched.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending as chatter increases around potential government investment in quantum computing firms, driving speculation about the company's future. Community members are discussing the significance of SEALSQ's focus on quantum-resistant chips and its potential alignment with national security priorities. Some traders are anticipating a short squeeze, while others point to the company's strong cash position and strategic partnerships as reasons for optimism.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors discuss its progress, including the shipping of B1 battery samples and customer billings, sparking optimism about the company's commercialization prospects. The community is actively speculating on potential OEM partnerships, drawing insights from industry announcements and executive comments. However, some remain cautious, citing fundamental risks like pre-revenue status and high valuation.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending as community members discuss the potential impact of a major Pentagon contract and Trump Jr.'s involvement with the company. Bullish sentiment revolves around the expectation of future government contracts and expansion into the private sector, particularly with drones. However, some are skeptical of the contract's immediate significance and question the timing of the news.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is experiencing notable activity amid discussions around institutional investment, specifically Lynx Capital's increased stake, and its potential impact on the stock's trajectory. Community members are weighing the possibility of a short squeeze against concerns about potential dilution, while also noting the company's partnership with Merck. Traders are actively monitoring price levels and technical indicators, contributing to the heightened interest in NEUP.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to a potential breakthrough in quantum computing, with successful tests using AMD chips sparking renewed interest in the sector; community discussions highlight the long-term potential and comparisons to other quantum computing stocks, with some traders pointing to IBM's established market presence; this news arrives ahead of anticipated earnings, creating a focal point for investors.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as it acquires Railbird, signaling entry into the prediction market space, a move seen as a potential challenge to competitors like Kalshi. The community is debating whether this will offset concerns about prediction markets cannibalizing the sports betting business, with some expecting a positive impact while others remain skeptical. Discussions also involve the broader implications for DraftKings' market position and potential regulatory responses.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

LUMN is trending as investors discuss its potential in the AI infrastructure space, particularly following news of a partnership. Community members are focused on the stock's long-term prospects and potential for a short squeeze, while acknowledging the company's debt. The discussion highlights the potential for LUMN to transition from legacy telecom to a key player in the AI-driven economy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire NEW YORK, Oct. 15, 2025 NEW YORK, Oct. 15, 2025...

PAVmed (PAVM) Upgraded to Strong Buy: Here's Why

PAVmed (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire NEW YORK, Feb. 25, 2025 NEW...

PAVmed and Subsidiary Veris Health Complete Private Placement Financing

PAVmed and Subsidiary Veris Health Complete Private Placement Financing PAVmed and Subsidiary Veris Health Complete Private Placement Financing PR Newswire NEW YORK, Feb. 24, 2025 Gross proceeds of...

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health

Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health PR Newswire NEW YORK, Feb. 20, 2025 LEAA...

PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement

PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement PR Newswire NEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18...

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital...

Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume

Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume PR Newswire NEW YORK, Jan. 13, 2025 Quarterly test volume of over...

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid...

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for...

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$0.4107
Prev Close	$0.4292
Open	$0.4071
Dividend Yield	0.00%
50-Day Moving Average	$0.4549
Beta	1.25
Avg. Volume	224,133.05
PE Ratio	0.37

52-Week High	$1.25
52-Week Low	$0.304
Market Capitalization	$9.28M
EPS (Annual)	$0.4961
Price to Book	0.67
Revenue Per Employee	$76,794.87
Enterprise Value/EBITDA	N/A

PAVM
PAVmed Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PAVM News

PAVMPAVmed Inc